A randomized trial of intravenous acetaminophen versus indomethacin for treatment of hemodynamically significant PDAs in VLBW infants
- PMID: 32439957
- DOI: 10.1038/s41372-020-0694-1
A randomized trial of intravenous acetaminophen versus indomethacin for treatment of hemodynamically significant PDAs in VLBW infants
Abstract
Objective was to compare the rate of successful treatment of hsPDA based on echocardiogram criteria after use of IV acetaminophen or IV indomethacin in very low-birthweight infants. The study was a multi-center, randomized controlled trial. Infants born prior to 32 weeks with birthweight ≤ 1500 g were included if PDA treatment was indicated within the 21 days after birth. hsPDA was defined by strict echocardiogram criteria. Eligible infants were randomized to treatment with either IV acetaminophen or IV indomethacin. Of 86 eligible infants, 17 infants were randomized to acetaminophen and 20 to indomethacin. One (5.9%) hsPDA in the acetaminophen group had successful treatment compared to 11 (55%) in the indomethacin group (p = 0.002). Eight (47%) in the acetaminophen group and 3 (15%) in the indomethacin group received transcatheter PDA closure (p = 0.07). IV indomethacin was more effective than IV acetaminophen for treatment of hsPDAs. More infants in the acetaminophen group received transcatheter closure.
Similar articles
-
A Network Meta-Analysis of Intravenous Versus Oral Acetaminophen for Patent Ductus Arteriosus.Pediatr Cardiol. 2023 Apr;44(4):748-756. doi: 10.1007/s00246-022-03053-1. Epub 2022 Nov 24. Pediatr Cardiol. 2023. PMID: 36422654 Review.
-
Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320).J Perinatol. 2019 May;39(5):599-607. doi: 10.1038/s41372-019-0347-4. Epub 2019 Mar 8. J Perinatol. 2019. PMID: 30850756 Free PMC article. Clinical Trial.
-
Oral indomethacin versus oral ibuprofen for treatment of patent ductus arteriosus: a randomised controlled study in very low-birthweight infants.Paediatr Int Child Health. 2018 Aug;38(3):187-192. doi: 10.1080/20469047.2018.1483566. Epub 2018 Jun 18. Paediatr Int Child Health. 2018. PMID: 29912679 Clinical Trial.
-
Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.Cochrane Database Syst Rev. 2020 Feb 11;2(2):CD003481. doi: 10.1002/14651858.CD003481.pub8. Cochrane Database Syst Rev. 2020. PMID: 32045960 Free PMC article.
-
Effectiveness of Dual Medication Therapy (Oral Acetaminophen and Oral Ibuprofen) for the Management of Patent Ductus Arteriosus in Extremely Premature Infants: A Feasibility Trial.Am J Perinatol. 2022 Sep;39(12):1326-1333. doi: 10.1055/s-0040-1722329. Epub 2021 Jan 17. Am J Perinatol. 2022. PMID: 33454945
Cited by
-
Management of Patent Ductus Arteriosus in Premature Infants in 2020.Front Pediatr. 2021 Feb 11;8:590578. doi: 10.3389/fped.2020.590578. eCollection 2020. Front Pediatr. 2021. PMID: 33643964 Free PMC article. Review.
-
Comparison of Various Pharmacologic Agents in the Management of Hemodynamically Significant Patent Ductus Arteriosus in Preterm: A Network Meta-Analysis and Risk-Benefit Analysis.Biomed Hub. 2022 Oct 24;7(3):125-145. doi: 10.1159/000526318. eCollection 2022 Sep-Dec. Biomed Hub. 2022. PMID: 36465804 Free PMC article. Review.
-
Acetaminophen and the Developing Lung: Could There Be Lifelong Consequences?J Pediatr. 2021 Aug;235:264-276.e1. doi: 10.1016/j.jpeds.2021.02.026. Epub 2021 Feb 20. J Pediatr. 2021. PMID: 33617854 Free PMC article. Review. No abstract available.
-
Pharmacological pain and sedation interventions for the prevention of intraventricular hemorrhage in preterm infants on assisted ventilation - an overview of systematic reviews.Cochrane Database Syst Rev. 2023 Aug 11;8(8):CD012706. doi: 10.1002/14651858.CD012706.pub2. Cochrane Database Syst Rev. 2023. PMID: 37565681 Free PMC article. Review.
-
A Network Meta-Analysis of Intravenous Versus Oral Acetaminophen for Patent Ductus Arteriosus.Pediatr Cardiol. 2023 Apr;44(4):748-756. doi: 10.1007/s00246-022-03053-1. Epub 2022 Nov 24. Pediatr Cardiol. 2023. PMID: 36422654 Review.
References
-
- Alagarsamy S, Chhabra M, Gudavalli M, Nadroo AM, Sutija VG, Yugrakh D. Comparison of clinical criteria with echocardiographic findings in diagnosing PDA in preterm infants. J Perinat Med. 2005;33:161–4. - PubMed
-
- Davis P, Turner-Gomes S, Cunningham K, Way C, Roberts R, Schmidt B. Precision and accuracy of clinical and radiological signs in premature infants at risk of patent ductus arteriosus. Arch Pediatr Adolesc Med. 1995;149:1136–41. - PubMed
-
- Skelton R, Evans N, Smythe J. A blinded comparison of clinical and echocardiographic evaluation of the preterm infant for patent ductus arteriosus. J Paediatr Child Health. 1994;30:406–11. - PubMed
-
- Zonnenberg I, de Waal K. The definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature review. Acta Paediatr. 2012;101:247–51. - PubMed
-
- Silverman NH, Lewis AB, Heymann MA, Rudolph AM. Echocardiographic assessment of ductus arteriosus shunt in premature infants. Circulation. 1974;50:821–5. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources